Bagai Shaun 4
4 · RenovoRx, Inc. · Filed Apr 16, 2025
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Bagai Shaun
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2025-04-14+409,992→ 409,992 totalExercise: $0.84→ Common Stock (409,992 underlying)
Footnotes (1)
- [F1]On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 409,992 shares of the Issuer's common stock (187,812 shares of which are underlying incentive stock options and 222,180 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035.